Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 12

Trial Status

Recruiting2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT07018518Phase 1Recruiting
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
AdultHepatocellular Carcinoma
StudydirectorStart date: 2025-06-20
NCT06883149Phase 1Recruiting
PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor
AdultSolid Tumor
StudydirectorStart date: 2025-03-19

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Interventional radiology, Chinese PLA General Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Weidong Han, Ph.D

Biotherapeutic Department, Chinese PLA General Hospital

Moderately Similar
12 trials

Shared therapeutic areas:

AdultSolid TumorCarcinoma, Hepatocellular

Worked with same sponsors:

Changping LaboratoryChinese PLA General Hospital
Collaborated on 2 trials
Similarity Score38%

Lilin Ye, Ph.D

Department of Tumor Immunology, Changping Laboratory

Moderately Similar
3 trials

Shared therapeutic areas:

AdultCarcinoma, HepatocellularSolid Tumor

Worked with same sponsors:

Changping LaboratoryChinese PLA General Hospital
Collaborated on 2 trials
Similarity Score38%

Guanghua Rong, Ph.D

Biotherapeutic Department, the Fifth Medical Center of the PLA General Hospital

Related
2 trials

Shared therapeutic areas:

AdultCarcinoma, Hepatocellular

Worked with same sponsors:

Changping LaboratoryChinese PLA General Hospital
Collaborated on 1 trial
Similarity Score24%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularSolid Tumor
Similarity Score20%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related
31 trials

Shared therapeutic areas:

Carcinoma, HepatocellularSolid Tumor
Similarity Score20%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score10%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Solid Tumor
Similarity Score10%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Solid Tumor
Similarity Score10%

Barbara Murphy, MD

Vanderbilt-Ingram Cancer Center

Related
14 trials

Shared therapeutic areas:

Solid Tumor
Similarity Score10%

Dong-Xin Wang, MD,PhD

Peking University First Hospital

Related
15 trials

Shared therapeutic areas:

Adult
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07018518Phase 1StudyDirector

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

AdultHepatocellular Carcinoma
Recruiting
NCT06883149Phase 1StudyDirector

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

AdultSolid Tumor
Recruiting

All 2 trials loaded